Bank Of New York Mellon Corp Ani Pharmaceuticals Inc Transaction History

Bank Of New York Mellon Corp

$529 Trillion
Q2 2025

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$37.61 - $45.72 $4.12 Million - $5.01 Million	109,489 New	109,489 $4.35 Billion
Q4 2022 Feb 14, 2023	BUY	$31.9 - $41.95 $3.64 Million - $4.79 Million	114,097 New	114,097 $4.59 Million
Q3 2022 Nov 14, 2022	SELL	$29.83 - $38.01 $16,406 - $20,905	-550 Reduced 0.45%	120,634 $3.88 Million
Q2 2022 Aug 15, 2022	SELL	$23.09 - $33.46 $43,917 - $63,640	-1,902 Reduced 1.55%	121,184 $3.6 Million
Q1 2022 May 11, 2022	SELL	$26.91 - $47.15 $492,264 - $862,514	-18,293 Reduced 12.94%	123,086 $3.46 Million
Q4 2021 Feb 11, 2022	BUY	$32.97 - $56.85 $1.5 Million - $2.59 Million	45,477 Added 47.42%	141,379 $6.52 Million
Q3 2021 Nov 12, 2021	BUY	$26.48 - $35.99 $54,336 - $73,851	2,052 Added 2.19%	95,902 $3.15 Million
Q2 2021 Aug 11, 2021	SELL	$31.86 - $38.6 $223,943 - $271,319	-7,029 Reduced 6.97%	93,850 $3.29 Million
Q1 2021 May 13, 2021	SELL	$28.4 - $36.14 $81,138 - $103,251	-2,857 Reduced 2.75%	100,879 $3.65 Million
Q4 2020 Feb 09, 2021	SELL	$23.69 - $31.47 $128,518 - $170,724	-5,425 Reduced 4.97%	103,736 $3.01 Million
Q3 2020 Nov 12, 2020	BUY	$26.38 - $33.1 $96,075 - $120,550	3,642 Added 3.45%	109,161 $3.08 Million
Q2 2020 Aug 12, 2020	BUY	$29.93 - $50.1 $25,440 - $42,585	850 Added 0.81%	105,519 $3.41 Million
Q1 2020 May 06, 2020	SELL	$30.35 - $67.14 $119,579 - $264,531	-3,940 Reduced 3.63%	104,669 $4.26 Million
Q4 2019 Feb 14, 2020	SELL	$55.65 - $79.83 $18,086 - $25,944	-325 Reduced 0.3%	108,609 $6.7 Million
Q3 2019 Nov 07, 2019	SELL	$64.7 - $85.39 $21,286 - $28,093	-329 Reduced 0.3%	108,934 $7.94 Million
Q2 2019 Aug 12, 2019	BUY	$67.77 - $82.2 $301,034 - $365,132	4,442 Added 4.24%	109,263 $8.98 Million
Q1 2019 May 14, 2019	SELL	$45.83 - $70.54 $1.36 Million - $2.1 Million	-29,768 Reduced 22.12%	104,821 $7.39 Million
Q4 2018 Feb 11, 2019	BUY	$41.17 - $56.44 $19,514 - $26,752	474 Added 0.35%	134,589 $6.06 Million
Q3 2018 Nov 09, 2018	SELL	$52.95 - $71.34 $76,353 - $102,872	-1,442 Reduced 1.06%	134,115 $0
Q2 2018 Aug 06, 2018	BUY	$56.38 - $68.08 $353,051 - $426,316	6,262 Added 4.84%	135,557 $9.06 Million
Q1 2018 May 15, 2018	SELL	$56.98 - $72.41 $3.54 Million - $4.5 Million	-62,147 Reduced 32.46%	129,295 $7.53 Million
Q4 2017 Feb 09, 2018	BUY	$53.3 - $74.56 $10.2 Million - $14.3 Million	191,442	191,442 $12.3 Million

Others Institutions Holding ANIP

# of Institutions

243

Shares Held

20.5M

Call Options Held

19.9K

Put Options Held

12.8K

Black Rock Inc. New York, NY

2.66M
Shares

$235 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.28M
Shares

$113 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

1M
Shares

$88.7 Million
0.03% of portfolio
Global Alpha Capital Management Ltd.

862K
Shares

$76.2 Million
3.45% of portfolio
State Street Corp Boston, MA

716K
Shares

$63.3 Million
0.0% of portfolio

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.54B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account